Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies [Phase 4]
Phase 4 clinical trial update evaluating efalizumab in adults with moderate-to-severe chronic psoriasis who have failed, have a contraindica…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study [Phase 3]
Phase 3 real-world study update evaluating the combination of adalimumab with methotrexate in psoriasis (the CLEAR Study) completed with res…
-
FDA approval · 2018-03-16FDA Approved: DESOXIMETASONE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' desoximetasone topical product under an original application, enabling a generic version of this topical…
-
FDA approval · 2018-03-15FDA Approved: METHOTREXATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Methotrexate submitted by Hospira, Inc.
-
CLINICAL_TRIALS research · 2018-03-14Clinical Trial Update: Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis [Phase 4]
Phase 4 clinical trial update comparing oral versus subcutaneous methotrexate for psoriasis; current status is not provided.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis [Phase 3]
Phase 3 study evaluating the safety, tolerability, and efficacy of secukinumab for moderate-to-severe nail psoriasis; results have been post…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis [Phase 3]
Polichem S.A. is conducting a Phase 3 trial to evaluate the efficacy and safety of P-3073 Nail Solution for nail psoriasis. The study status…
-
CLINICAL_TRIALS research · 2018-03-07Clinical Trial Update: A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis [Phase 1]
Phase 1 trial of PRCL-02 in healthy volunteers and individuals with plaque psoriasis has been completed.
-
CLINICAL_TRIALS research · 2018-03-06Clinical Trial Update: Identification of New Prognostic Markers in Psoriatic Arthritis [NA]
This clinical trial update reports the identification of new prognostic markers in Psoriatic arthritis. The study, conducted at IRCCS Ospeda…
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035 [Phase 1]
Phase 1 study to assess the safety, tolerability and pharmacokinetics of ABY-035; the trial was completed, including both psoriasis patients…
-
CLINICAL_TRIALS withdrawal · 2018-03-02Clinical Trial Update: Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis [NA]
This clinical trial update indicates that the study evaluating topical or oral calcitriol for psoriasis has been withdrawn.
-
FDA approval · 2018-02-13FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Encube Ethicals, Inc.)
FDA approved Betamethasone Dipropionate as an original application from Encube Ethicals, Inc. (ANDA206389) for topical use in inflammatory d…
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis [Phase 2]
Phase 2 trial update for dose-ranging study of R115966 in plaque psoriasis with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Enstilar in Combination With Biologic Agents [Phase 4]
Phase 4 trial update evaluating Enstilar in combination with biologic agents for psoriasis has been completed.
-
CLINICAL_TRIALS withdrawal · 2017-11-29Clinical Trial Update: A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects [Phase 1]
A Phase 1 pharmacokinetic and safety study of GSK2894512 in healthy adult subjects has been withdrawn.
-
FDA approval · 2017-11-21FDA Approved: HYDROCORTISONE BUTYRATE — Original Application (The J. Molner Company LLC)
The FDA approved a generic topical hydrocortisone butyrate product under an Original Application (ANDA 209556) from The J. Molner Company LL…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: A Study of SHR-1314 in Healthy Subjects [Phase 1]
Phase 1 study of SHR-1314 in healthy subjects has completed; psoriasis is listed as the condition associated with the trial.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 dose-finding study of GSK2894512 cream for plaque psoriasis completed. Results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 [Phase 2]
This report updates the completion of a Phase 2 study evaluating cellular and immunologic changes in the skin of psoriasis patients treated …
-
CLINICAL_TRIALS research · 2017-11-13Clinical Trial Update: Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases [NA]
This clinical-trial update reviews the mechanisms by which phototherapy and photochemotherapy exert therapeutic effects in skin diseases. It…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 [Phase 1]
Phase 1 study of a topical GW786034 for chronic plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study [Phase 1]
Phase 1 study of BAY1003803 in psoriasis was terminated. The trial evaluated single- and multiple-dose escalation, safety, tolerability, and…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment [Phase 3]
Phase 3 clinical trial update on guselkumab for moderate to severe plaque-type psoriasis with randomized withdrawal and retreatment.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis [Phase 1]
This clinical trial update describes a Phase 1 study of ABBV-553 assessing pharmacokinetics, safety and tolerability in healthy volunteers a…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or Lupus
A clinical trial update examining patient-centered care and health-related quality of life in people with psoriasis, urticaria, or systemic …